Anti-inflammatory Therapeutics Market - Global Outlook and Forecast 2022-2028

January 2022 | 72 pages | ID: AEAFE1624D71EN
Market Monitor Global

Abstracts

Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.

This report contains market size and forecasts of Anti-inflammatory Therapeutics in Global, including the following market information:

Global Anti-inflammatory Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Anti-inflammatory Therapeutics market was valued at 113740 million in 2021 and is projected to reach US$ 169200 million by 2028, at a CAGR of 5.8% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Anti-inflammatory Biologics Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Anti-inflammatory Therapeutics include AbbVie, Johnson & Johnson, Amgen Inc, AstraZeneca PLC, Pfizer, Inc, Novartis, Roche, Merck and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-inflammatory Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Anti-inflammatory Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Anti-inflammatory Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Anti-inflammatory Biologics
• Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
• Corticosteroids
• Others

Global Anti-inflammatory Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Anti-inflammatory Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Arthritis
• Respiratory Diseases
• Dermatology
• Gastroenterology
• Others

Global Anti-inflammatory Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Anti-inflammatory Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Anti-inflammatory Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Anti-inflammatory Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AbbVie
• Johnson & Johnson
• Amgen Inc
• AstraZeneca PLC
• Pfizer, Inc
• Novartis
• Roche
• Merck
• Sanofi
• GlaxoSmithKline
• Sun Pharmaceutical Industries Ltd
• TEVA

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Anti-inflammatory Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Anti-inflammatory Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTI-INFLAMMATORY THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Anti-inflammatory Therapeutics Market Size: 2021 VS 2028
2.2 Global Anti-inflammatory Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Anti-inflammatory Therapeutics Players in Global Market
3.2 Top Global Anti-inflammatory Therapeutics Companies Ranked by Revenue
3.3 Global Anti-inflammatory Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Anti-inflammatory Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Anti-inflammatory Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-inflammatory Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Anti-inflammatory Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Anti-inflammatory Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Anti-inflammatory Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Anti-inflammatory Biologics
  4.1.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
  4.1.4 Corticosteroids
  4.1.5 Others
4.2 By Type - Global Anti-inflammatory Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Anti-inflammatory Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Anti-inflammatory Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Anti-inflammatory Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Anti-inflammatory Therapeutics Market Size, 2021 & 2028
  5.1.2 Arthritis
  5.1.3 Respiratory Diseases
  5.1.4 Dermatology
  5.1.5 Gastroenterology
  5.1.6 Others
5.2 By Application - Global Anti-inflammatory Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Anti-inflammatory Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Anti-inflammatory Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Anti-inflammatory Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Anti-inflammatory Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Anti-inflammatory Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Anti-inflammatory Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Anti-inflammatory Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Anti-inflammatory Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Anti-inflammatory Therapeutics Revenue, 2017-2028
  6.3.2 US Anti-inflammatory Therapeutics Market Size, 2017-2028
  6.3.3 Canada Anti-inflammatory Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Anti-inflammatory Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Anti-inflammatory Therapeutics Revenue, 2017-2028
  6.4.2 Germany Anti-inflammatory Therapeutics Market Size, 2017-2028
  6.4.3 France Anti-inflammatory Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Anti-inflammatory Therapeutics Market Size, 2017-2028
  6.4.5 Italy Anti-inflammatory Therapeutics Market Size, 2017-2028
  6.4.6 Russia Anti-inflammatory Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Anti-inflammatory Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Anti-inflammatory Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Anti-inflammatory Therapeutics Revenue, 2017-2028
  6.5.2 China Anti-inflammatory Therapeutics Market Size, 2017-2028
  6.5.3 Japan Anti-inflammatory Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Anti-inflammatory Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Anti-inflammatory Therapeutics Market Size, 2017-2028
  6.5.6 India Anti-inflammatory Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Anti-inflammatory Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Anti-inflammatory Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Anti-inflammatory Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Anti-inflammatory Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Anti-inflammatory Therapeutics Market Size, 2017-2028
  6.7.3 Israel Anti-inflammatory Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Anti-inflammatory Therapeutics Market Size, 2017-2028
  6.7.5 UAE Anti-inflammatory Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AbbVie
  7.1.1 AbbVie Corporate Summary
  7.1.2 AbbVie Business Overview
  7.1.3 AbbVie Anti-inflammatory Therapeutics Major Product Offerings
  7.1.4 AbbVie Anti-inflammatory Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 AbbVie Key News
7.2 Johnson & Johnson
  7.2.1 Johnson & Johnson Corporate Summary
  7.2.2 Johnson & Johnson Business Overview
  7.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Major Product Offerings
  7.2.4 Johnson & Johnson Anti-inflammatory Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Johnson & Johnson Key News
7.3 Amgen Inc
  7.3.1 Amgen Inc Corporate Summary
  7.3.2 Amgen Inc Business Overview
  7.3.3 Amgen Inc Anti-inflammatory Therapeutics Major Product Offerings
  7.3.4 Amgen Inc Anti-inflammatory Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Amgen Inc Key News
7.4 AstraZeneca PLC
  7.4.1 AstraZeneca PLC Corporate Summary
  7.4.2 AstraZeneca PLC Business Overview
  7.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Major Product Offerings
  7.4.4 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 AstraZeneca PLC Key News
7.5 Pfizer, Inc
  7.5.1 Pfizer, Inc Corporate Summary
  7.5.2 Pfizer, Inc Business Overview
  7.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Major Product Offerings
  7.5.4 Pfizer, Inc Anti-inflammatory Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Pfizer, Inc Key News
7.6 Novartis
  7.6.1 Novartis Corporate Summary
  7.6.2 Novartis Business Overview
  7.6.3 Novartis Anti-inflammatory Therapeutics Major Product Offerings
  7.6.4 Novartis Anti-inflammatory Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Novartis Key News
7.7 Roche
  7.7.1 Roche Corporate Summary
  7.7.2 Roche Business Overview
  7.7.3 Roche Anti-inflammatory Therapeutics Major Product Offerings
  7.7.4 Roche Anti-inflammatory Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Roche Key News
7.8 Merck
  7.8.1 Merck Corporate Summary
  7.8.2 Merck Business Overview
  7.8.3 Merck Anti-inflammatory Therapeutics Major Product Offerings
  7.8.4 Merck Anti-inflammatory Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Merck Key News
7.9 Sanofi
  7.9.1 Sanofi Corporate Summary
  7.9.2 Sanofi Business Overview
  7.9.3 Sanofi Anti-inflammatory Therapeutics Major Product Offerings
  7.9.4 Sanofi Anti-inflammatory Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Sanofi Key News
7.10 GlaxoSmithKline
  7.10.1 GlaxoSmithKline Corporate Summary
  7.10.2 GlaxoSmithKline Business Overview
  7.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Major Product Offerings
  7.10.4 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 GlaxoSmithKline Key News
7.11 Sun Pharmaceutical Industries Ltd
  7.11.1 Sun Pharmaceutical Industries Ltd Corporate Summary
  7.11.2 Sun Pharmaceutical Industries Ltd Business Overview
  7.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Major Product Offerings
  7.11.4 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue in Global Market (2017-2022)
  7.11.5 Sun Pharmaceutical Industries Ltd Key News
7.12 TEVA
  7.12.1 TEVA Corporate Summary
  7.12.2 TEVA Business Overview
  7.12.3 TEVA Anti-inflammatory Therapeutics Major Product Offerings
  7.12.4 TEVA Anti-inflammatory Therapeutics Revenue in Global Market (2017-2022)
  7.12.5 TEVA Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Anti-inflammatory Therapeutics Market Opportunities & Trends in Global Market
Table 2. Anti-inflammatory Therapeutics Market Drivers in Global Market
Table 3. Anti-inflammatory Therapeutics Market Restraints in Global Market
Table 4. Key Players of Anti-inflammatory Therapeutics in Global Market
Table 5. Top Anti-inflammatory Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Anti-inflammatory Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Anti-inflammatory Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Anti-inflammatory Therapeutics Product Type
Table 9. List of Global Tier 1 Anti-inflammatory Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-inflammatory Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Anti-inflammatory Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Anti-inflammatory Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Anti-inflammatory Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Anti-inflammatory Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Anti-inflammatory Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Anti-inflammatory Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. AbbVie Corporate Summary
Table 31. AbbVie Anti-inflammatory Therapeutics Product Offerings
Table 32. AbbVie Anti-inflammatory Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Johnson & Johnson Corporate Summary
Table 34. Johnson & Johnson Anti-inflammatory Therapeutics Product Offerings
Table 35. Johnson & Johnson Anti-inflammatory Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Amgen Inc Corporate Summary
Table 37. Amgen Inc Anti-inflammatory Therapeutics Product Offerings
Table 38. Amgen Inc Anti-inflammatory Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. AstraZeneca PLC Corporate Summary
Table 40. AstraZeneca PLC Anti-inflammatory Therapeutics Product Offerings
Table 41. AstraZeneca PLC Anti-inflammatory Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer, Inc Corporate Summary
Table 43. Pfizer, Inc Anti-inflammatory Therapeutics Product Offerings
Table 44. Pfizer, Inc Anti-inflammatory Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Novartis Corporate Summary
Table 46. Novartis Anti-inflammatory Therapeutics Product Offerings
Table 47. Novartis Anti-inflammatory Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Roche Corporate Summary
Table 49. Roche Anti-inflammatory Therapeutics Product Offerings
Table 50. Roche Anti-inflammatory Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Merck Corporate Summary
Table 52. Merck Anti-inflammatory Therapeutics Product Offerings
Table 53. Merck Anti-inflammatory Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Sanofi Corporate Summary
Table 55. Sanofi Anti-inflammatory Therapeutics Product Offerings
Table 56. Sanofi Anti-inflammatory Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. GlaxoSmithKline Corporate Summary
Table 58. GlaxoSmithKline Anti-inflammatory Therapeutics Product Offerings
Table 59. GlaxoSmithKline Anti-inflammatory Therapeutics Revenue (US$, Mn), (2017-2022)
Table 60. Sun Pharmaceutical Industries Ltd Corporate Summary
Table 61. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product Offerings
Table 62. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue (US$, Mn), (2017-2022)
Table 63. TEVA Corporate Summary
Table 64. TEVA Anti-inflammatory Therapeutics Product Offerings
Table 65. TEVA Anti-inflammatory Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Anti-inflammatory Therapeutics Segment by Type in 2021
Figure 2. Anti-inflammatory Therapeutics Segment by Application in 2021
Figure 3. Global Anti-inflammatory Therapeutics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Anti-inflammatory Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anti-inflammatory Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-inflammatory Therapeutics Revenue in 2021
Figure 8. By Type - Global Anti-inflammatory Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Anti-inflammatory Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Anti-inflammatory Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Anti-inflammatory Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Anti-inflammatory Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Anti-inflammatory Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Anti-inflammatory Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Anti-inflammatory Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. AbbVie Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Johnson & Johnson Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Amgen Inc Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. AstraZeneca PLC Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer, Inc Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Roche Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Merck Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Sanofi Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. GlaxoSmithKline Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. TEVA Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)